Even & Correct Advanced Brightening Treatment
$114. $178.
This price is available only in the spa. Appointment Required
Even & Correct Advanced Brightening Treatment is a powerful daily serum that helps target and prevent visible hyperpigmentation.
Hydroquinone-free and Retinol-free
Clinically proven to:
Clinically proven to treat the appearance of melasma, and other stubborn hyperpigmentation conditions
Clinically proven to prevent the appearance of future discoloration.
Non-hydroquinone, retinol-free, fragrance-free formulation
Key Ingredients:
9% LTN Complext™
Ultra-concentrated lotus sprout extract (addresses skin discoloration), tranexamic acid (brightening agent that reduces the appearance of dark spots), niacinamide (reduces the appearance of skin discoloration, fine lines, and yellow appearance).
Vitis Vinifera
Add moisture to dull, dehydrated skin; evens out skin tone; reduces the appearance of fine lines and wrinkles.
Plankton Extracti
Preserves and promotes even skin tone.
Phenylethyl Resorcinoll
Helps support melanin balance to correct the appearance of hyperpigmentation.
Phytic Acid
Enhances skin texture and promotes even-looking skin.
For all skin types • TSA Friendly • Silicone-free • Non-comedogenic • Sulfate-free • Lightweight • Fragrance-free • Paraben-free • Pilling-free
There's skincare. Then there's scientific skincare.
And with over 80 beauty award wins! SkinMedica is recognized as a leader in aesthetics.
Proof is in the Science
Explore peer-reviewed publications that show the impact of growth factors
Fitzpatrick RE, Rostan, EF. Reversal of photodamage with topical growth factors: a pilot study. J Cosmet Laser Ther. 2003:5:25-34.
Fitzpatrick RE. Treatment of photodamaged and aging skin with a unique cream: 3 Case reports. Cosmet Dermatol. 2004; 17(9):591-596.
Mehta RC, Fitzpatrick RE. Endogenous growth factors as cosmeceuticals. Dermatol Ther. 2007;Sep-Oct;20(5):350-9. .
Mehta RC, Smith SR, Grove GL, et al. Reduction in facial photodamage by a topical growth factor product. J Drugs Dermatol. 2008;7864-871. .
Trookman NS, Rizer RL, Ford R, et al. Immediate and long-term clinical benefits of a topical treatment for facial lines and wrinkles. J Clin Aesthet Dermatol. 2009; 2(3):38-43.
Sundaram H, Mehta RC, Norine JA, Kircik L, et al. Topically applied physiologically balanced growth factors: a new paradigm of skin rejuvenation. J Drugs Dermatol. 2009 May;8(5 Suppl Skin Rejuvenation):4-13.
Trookman NS, Rizer RL, Ford R, et al. Clinical assessment of a combination lip treatment to restore moisturization and fullness. J Clin Aesthet Dermatol. 2009; 2(12):44-48.
Atkin DH, Trookman NS, Rizer RL, et al. Combination of physiologically balanced growth factors with antioxidants for reversal of facial photodamage. J Cosmet Laser Ther. 2010; 12:14-20.
Kadoya K, Makino ET, Jiang, LI, et al. Upregulation of Extracellular Matrix Genes Corroborates Clinical Efficacy of Human Fibroblast-Derived Growth Factors in Skin Rejuvenation. J Drugs Dermatol. 2017; 16(12):1190-6.
Naughton GK, Jiang LI, Makino ET, et al. Targeting Multiple Hallmarks of Skin Aging: Preclinical and Clinical Efficacy of a Novel Growth Factor-Based Skin Care Serum. Dermatol Ther. 2023 Jan;13(1):169-186.
Gold MH, Wilson A, Makino E, et al. Improvements in Skin Quality Parameters in Postmenopausal Participants After Use of Topical Growth Factor Serum. J Cosmet Dermatol. 2023 Jan;22(1):236-244.
Goldman MP, Boen M, Deaver J, et al. Effects of a Topical Growth Factor Regimen Following Pre-elected Cosmetic Facial Injection Procedures. J Drugs Dermatol. 2023 Jan 1;22(1):9-15.
Kellar RS, Hubka M, Rheins LA, et al. Hypoxic conditioned culture medium from fibroblasts grown under embryonic-like conditions supports healing following post-laser resurfacing. J Cosmetic Derm. 2009; 8(3):190-196.
Pinney E, Zimber M, Schenone A, et al. Human Embryonic-like ECM (hECM) Stimulates Proliferation and Differentiation in Stem Cells While Killing Cancer Cells. Int J Stem Cells 2011; 4(1):70-75.
Zimber MP, Mansbridge JN, Taylor M, et al. Human cell-conditioned media produced under embryonic-like conditions result in improved healing time after laser resurfacing. Aesthetic Plast Surg. 2012; 36(2):431-437.
Bruce S, Karnik J, Dryer L, et al. Anti-aging proof of concept study: results and summary. J Drugs Dermatol. 2014; 13(9):1074-1081.
Sundaram H, Gold M, Waldorf H, et al. Pilot, Multicenter, Open-Label Evaluation of Safety, Tolerability and Efficacy of a Novel, Topical Multipotent Growth Factor Formulation for the Periorbital Region. J Drugs Dermatol. 2015; 14(12):1410-1417.
Draelos ZD, Karnik J, Naughton G. The Anti-Aging Effects of Low Oxygen Tension Generated Multipotent Growth Factor Containing Serum. J Drugs Dermatol. 2017; 16(1):30-34.
And many more at skinmedica.com